Kaya Holdings (KAYS) Total Debt Growth (1y) (2012 - 2025)
Kaya Holdings (KAYS) Total Debt Growth (1y) (2012 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn | -0.14% |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn | 37.52% |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn | -92.65% |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn | -9.19% |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn | - |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn | 0.63% |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn | - |
| 10 | Kaya Holdings | - | - | 5,370.00 | -88.55% |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -88.55% |
| Jun 30, 2025 | 92.44% |
| Mar 31, 2025 | -65.08% |
| Dec 31, 2024 | -14.77% |
| Sep 30, 2024 | 13.47% |
| Jun 30, 2024 | -45.87% |
| Mar 31, 2024 | 99.84% |
| Dec 31, 2023 | -77.57% |
| Sep 30, 2023 | -58.05% |
| Jun 30, 2023 | 172.56% |
| Mar 31, 2023 | -4.56% |
| Dec 31, 2022 | 12.33% |
| Mar 31, 2022 | 2,211.83% |
| Dec 31, 2021 | -32.22% |
| Sep 30, 2019 | 0.00% |
| Jun 30, 2019 | -97.39% |
| Dec 31, 2018 | -98.08% |
| Jun 30, 2018 | 126.21% |
| Dec 31, 2017 | 49.89% |
| Dec 31, 2016 | 8,845.58% |